• World News
  • Politics
  • Stock
  • Investing
  • Editor’s Pick
Time And Sales Reporter
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post
5 Biggest Blockchain ETFs in 2025
next post
Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Related Posts

Tartisan Nickel Corp. Intersects 24.6 Metres of 0.71%...

March 13, 2026

CHARBONE presentera a la conference Hydrogen East et...

March 13, 2026

Cartier Cuts 7.1 g/t Au over 8.0 m...

March 13, 2026

NevGold Mobilizes Drill To Test Historical Leach Pads...

March 13, 2026

LaFleur Minerals Inc.Taking Key Steps to Advance Position...

March 13, 2026

Uranium Supply Behind, Demand Evolving — What’s Next?...

March 12, 2026







    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.




    Recent Posts

    • House Republicans pass DHS funding bill that Democrats call ‘dead on arrival’ in the Senate

      March 31, 2026
    • God and bitcoin: Why some Christians are going all in on cryptocurrency

      March 31, 2026
    • Iran’s internet blackout hiding strike damage and suppressing dissent, Israeli officials say

      March 31, 2026
    • Internet erupts over ‘disqualifying’ leaked audio from Democrat in key Senate race discussing Khamenei’s death

      March 31, 2026
    • Key US ally blocks airspace to military flights over Iran, escalating standoff with Trump

      March 31, 2026
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 timeandsalesreporter.com | All Rights Reserved

    Time And Sales Reporter
    • World News
    • Politics
    • Stock
    • Investing
    • Editor’s Pick

    Read alsox

    Syntholene Energy: High-performance, Carbon-negative, Low-cost – the promise...

    January 16, 2026

    Tech 5: Tesla Pulls Plug on Dojo, Chipmakers...

    August 11, 2025

    Agreement to Acquire Major Drill-Ready Antimony-Gold-Tungsten Project in...

    June 11, 2025